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ABSTRACT Changes in the expression of potassium (K+) channels is a pivotal event during 
skeletal muscle differentiation. In mouse C2C12 cells, similarly to human skeletal muscle cells, 
myotube formation increased the expression of Kv7.1, Kv7.3, and Kv7.4, the last showing the 
highest degree of regulation. In C2C12 cells, Kv7.4 silencing by RNA interference reduced the 
expression levels of differentiation markers (myogenin, myosin heavy chain, troponinT-1, and 
Pax3) and impaired myotube formation and multinucleation. In Kv7.4-silenced cells, the dif-
ferentiation-promoting effect of the Kv7 activator N-(2-amino-4-(4-fluorobenzylamino)-
phenyl)-carbamic acid ethyl ester (retigabine) was abrogated. Expression levels for the re-
pressor element-1 silencing transcription factor (REST) declined during myotube formation. 
Transcript levels for Kv7.4, as well as for myogenin, troponinT-1, and Pax3, were reduced by 
REST overexpression and enhanced upon REST suppression by RNA interference. Four re-
gions containing potential REST-binding sites in the 5′ untranslated region and in the first in-
tron of the Kv7.4 gene were identified by bioinformatic analysis. Chromatin immunoprecipita-
tion assays showed that REST binds to these regions, exhibiting a higher efficiency in 
myoblasts than in myotubes. These data suggest that Kv7.4 plays a permissive role in skeletal 
muscle differentiation and highlight REST as a crucial transcriptional regulator for this K+ 
channel subunit.
INTRODUCTION
Highly coordinated changes in membrane potential of skeletal mus-
cle cells regulate the early stages of myogenesis, allowing proliferat-
ing myoblasts to withdraw from the cell cycle and fuse in ordered 
arrays of large, multinucleated myotubes (Walsh and Perlman, 1997). 
In fact, membrane hyperpolarization is known to trigger myoblast 
commitment and fusion (Bijlenga et al., 2000). Potassium (K+) chan-
nels act as major controllers of membrane potential; thus, a specific 
pattern of sequential changes in the expression and function of dis-
tinct classes of voltage-sensitive and voltage-insensitive K+ channels 
is a critical step in myoblast to myotube transition both in vitro and 
in vivo (Lesage et al., 1992; Cooper, 2001). Indeed, Kv10.1 (Bijlenga 
et al., 1998), KIR2.1 (Wieland and Gong, 1995; Fischer-Lougheed 
et al., 2001), Kv1.5 (Villalonga et al., 2008), and IKCa channels (Fioretti 
et al., 2005) have been shown to play specific roles in various as-
pects of skeletal muscle cell proliferation, differentiation, and/or 
survival.
The Kv7 subclass of voltage-dependent K+ channels consists of 
five members (Kv7.1– Kv7.5), all implicated in membrane potential 
control in excitable and nonexcitable cells (Soldovieri et al., 2011). 
Kv7.1 subunits form the molecular basis of the cardiac repolarizing 
current IKs and are mutated in genetically determined human ar-
rhythmias. Kv7.2, Kv7.3, Kv7.4, and Kv7.5 give rise to K+ currents 
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Regulation of in vitro skeletal muscle differentiation 
by Kv7.4
To evaluate the role played by Kv7.4 in skeletal muscle differentia-
tion, C2C12 cells were transiently transfected with a plasmid encod-
ing for a short hairpin RNA (shRNA) directed against Kv7.4 mRNA 
(pLKO.1-shKv7.4) 1 d before DM exposure for 48 h; in these ex-
periments, C2C12 cells transfected with a plasmid carrying a non-
sense sequence (pLKO.1-scramble) served as controls. In C2C12 
myoblasts, pLKO.1-shKv7.4 specifically suppressed Kv7.4 mRNA 
expression, with no effect on the transcripts encoding for other 
Kv7 members (Supplemental Figure S2). In shKv7.4-transfected 
myotubes, Kv7.4 mRNA (Figure 1A) and protein (Figure 1B) ex-
pression levels were markedly reduced (by >90% and ∼50%, re-
spectively); in these cells, the mRNA levels for the closely related 
Kv7.2 gene were unaffected by pLKO.1-shKv7.4 transfection 
(Figure 1A). In shKv7.4-transfeced C2C12 myotubes, a marked re-
duction of the mRNA levels for Myog, Pax3, and TnT-1 (Figure 1A), 
as well as of MyHC protein expression (Figure 1B), was observed.
To assess whether Kv7.4 silencing affected myogenesis beside 
protein markers, and to evaluate whether differentiation was sup-
pressed or delayed, the expression of MyHC was monitored at vari-
ous time points (2, 3, 4, and 7 d) in immunocytochemical experi-
ments. The results showed that, particularly at later time points (after 
4–7 d), silencing of Kv7.4 impaired myotube formation; in fact, 
Kv7.4-silenced cells exposed to differentiating conditions did not 
increase their cell size and displayed an impaired multinucleation 
(Figure 2A), resulting in a marked decrease in the cell fusion index 
(Figure 2B).
Pharmacological experiments revealed that 10,10-bis(4-
pyridinylmethyl)-9(10H)-anthracenone (XE-991), a rather specific 
inhibitor of channels formed by Kv7 subunits (Wang et al., 1998; 
Zaczek et al., 1998), when used at 30 μM was able to impede myo-
genesis, as revealed by the reduced expression of Myog and TnT-1 
in C2C12 myotubes; consistent with previous results (Iannotti et al., 
2010), lower drug concentrations (0.6–10 μM) were ineffective 
(Supplemental Figure S3).
Retigabine (10 μM), a specific activator of channels formed by 
Kv7.2–Kv7.5 subunits, enhanced C2C12 cell in vitro differentiation 
(Iannotti et al., 2010); it is noteworthy that in DM-exposed Kv7.4-
silenced cells, the effects of retigabine on C2C12 cell differentiation 
were completely abolished, as revealed by the loss of the ability of 
this Kv7 activator to increase the expression of TnT-1 (Figure 3A) 
and Pax3 (Figure 3B).
Whereas skeletal muscle differentiation was dramatically im-
peded upon suppression of Kv7.4 expression, no significant changes 
in the transcript levels for Myog, Pax3, and TnT-1 (Figure 4A) or in 
MyHC expression (Figure 4B) were detected when Kv7.4 was over-
expressed by transient transfection in C2C12 cells 1 d before DM 
exposure (48 h). Similarly, Kv7.4 transfection in proliferating C2C12 
cells not subsequently exposed to DM also failed to induce the ex-
pression of TnT-1, Myog, and Pax3 (Supplemental Figure S4).
Although Kv7.4 hyperexpression per se did not modify skeletal 
myogenesis, Kv7.4-overexpressing cells showed an enhanced sensi-
tivity to the differentiation-promoting effect of retigabine when 
compared with control cells; in fact, in Kv7.4-transfected cells, this 
neural Kv7 activator (10 μM) increased the transcript levels of TnT-1 
and Myog by sixfold to eightfold; in control cells, TnT-1 (Figure 5A, 
left) and Myog (Figure 5A, right) were increased by twofold to three-
fold upon exposure to the same drug concentration.
To investigate the mechanisms underlying the difference between 
Kv7.4 hyperexpression per se and retigabine on C2C12 cell differen-
tiation, we performed patch-clamp recordings in the whole-cell 
widely distributed in neuronal and primary sensory cells. Hetero-
meric assembly of Kv7.2 and Kv7.3 subunits underlies the muscar-
inic-regulated current IKM, a primary controller of neuronal excitabil-
ity (Wang et al., 1998); gene defects in Kv7.2 or Kv7.3 are responsible 
for benign familial neonatal seizures, an inherited epilepsy of the 
newborn (Maljevic et al., 2010). Kv7.4 is expressed in primary sen-
sory cells of the inner ear, and its mutations cause a rare form of 
nonsyndromic autosomal-dominant hearing loss type 2 (DFNA2; 
Soldovieri et al., 2011). Expression and function of some Kv7 gene 
family members are not restricted to the nervous system but have 
been also detected in thyroid gland, pancreas, stomach, and intes-
tine (Maljevic et al., 2010); moreover, Kv7.4 and Kv7.5 are expressed 
in smooth muscle cells from several vascular beds, where they con-
tribute to vessel tone regulation (Mackie and Byron, 2008). Expres-
sion of Kv7 gene family members has also been detected in skeletal 
muscle cells (Lerche et al., 2000; Schroeder et al., 2000; Tsevi et al., 
2005; Roura-Ferrer et al., 2008). In murine C2C12 cells, a widely used 
in vitro model for skeletal myogenesis, we previously showed that 
myotube formation was accompanied by an up-regulation of Kv7.1, 
Kv7.3, and Kv7.4. In these cells, N-(2-amino-4-(4-fluorobenzylamino)-
phenyl)-carbamic acid ethyl ester (retigabine), a specific activator of 
neuronal Kv7.2–Kv7.5 subunits, reduced proliferation, accelerated 
myogenesis, and inhibited drug-induced myotoxic responses 
(Iannotti et al., 2010).
In the present study, we explore the functional role and transcrip-
tional regulation in myogenic development of Kv7.4, the Kv7 gene 
member showing the highest degree of up-regulation. To this aim, 
we modified expression levels of Kv7.4 by gene silencing or overex-
pression techniques in C2C12 cells; we evaluated skeletal myogen-
esis by means of quantitative PCR (qPCR), Western blot, and immu-
nocytochemical analysis of skeletal muscle–specific markers such as 
troponinT-1 (TnT-1), myogenin (Myog), Pax3, and myosin heavy 
chain (MyHC). In Kv7.4-silenced and Kv7.4-overexpressing cells, we 
assessed the effect of the Kv7 modulator retigabine on skeletal myo-
genesis and Kv7.4 currents by biochemical and electrophysiological 
experiments, respectively. Because in neuronal cells, the repressor 
element-1 silencing transcription factor (REST; Chong et al., 1995; 
Schoenherr and Anderson, 1995) controls the expression of genes 
involved in the acquisition of the differentiated phenotype 
(D’Alessandro and Meldolesi, 2010) and members of the Kv7 gene 
family are directly regulated by REST (Mucha et al., 2010), we inves-
tigated the REST-dependent transcriptional regulation of Kv7.4, as 
well as sites potentially involved, by bioinformatic analysis and chro-
matin immunoprecipitation (ChIP) assays.
RESULTS
Changes in Kv7 expression during in vitro myogenesis
Murine C2C12 myoblasts exposed for 48 h to differentiation medium 
(DM) showed a large increase in the expression levels of skeletal 
muscle–specific proteins such as TnT-1 and Myog and of myosin 
heavy chain (MyHC), a marker of late skeletal muscle cell maturation 
(Bennett and Tonks, 1997; Iannotti et al., 2010). Proliferating human 
primary myoblasts (hSkM-S), similarly to C2C12 myoblasts, expressed 
transcripts encoding for all members of the Kv7 subfamily; when 
these cells were cultured in DM for 48 h, the expression levels for 
Kv7.1, Kv7.3, and Kv7.4 were increased, with Kv7.4 showing the 
highest degree of modulation; by contrast, transcript levels for Kv7.2 
and Kv7.5 were not modified (Supplemental Figure S1). Given the 
similarities between murine C2C12 cells and human primary myo-
blasts with regard to the expression changes of the Kv7 subfamily 
members during in vitro myogenesis, all of the following experi-
ments were performed using the clonal murine cellular model.
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configuration using the perforated-patch technique. Given that en-
dogenous Kv7.4 currents in either C2C12 myoblasts or myotubes 
could not be resolved (see the inset in Figure 5B), we used C2C12 
myoblasts overexpressing Kv7.4 channels by transient transfection 
for these experiments. Heterologously expressed Kv7.4 channels 
gave rise to voltage-dependent, outwardly-directed K+ currents 
having a threshold of activation around −50 mV and displaying slow 
activation and deactivation kinetics (Figure 5B, top left). Perfusion 
FIGURE 1: Effect of Kv7.4 gene silencing on C2C12 cell differentiation. 
C2C12 myoblasts transfected with pLKO.1-scramble (control) or 
pLKO.1-shKv7.4 (shKv7.4) plasmids were exposed to DM for 48 h. 
(A) Kv7.4, Kv7.2, Myog, Pax3, and TnT-1 mRNA expression levels by 
qPCR. (B) Western blot analysis for Kv7.4 and MyHC protein 
expression on total lysates from control- or shKv7.4-tranfected cells. 
Top, a representative blot for Kv7.4, MyHC, and α-tubulin. The 
approximate molecular mass for each of these proteins (expressed in 
kDa) is shown on the right. Bottom, bar graph showing the 
quantification of the averaged OD values for the Kv7.4 and MyHC 
bands, normalized to the OD value for α-tubulin, in both control-
transfected (open columns) and shKv7.4-transfected (solid columns) 
C2C12 cells. *p ≤ 0.05 vs. respective control; data from three separate 
transfections for each experimental condition (scramble or 
shKv7.4 plasmid).
FIGURE 2: Immunocytochemical analysis of the effects of Kv7.4 gene 
silencing in C2C12 cells. C2C12 myoblasts transfected with pLKO.1-
scramble (control) or pLKO.1-shKv7.4 (shKv7.4) plasmids were 
exposed to DM for the time indicated on the left. (A) Kv7.4 (green 
pseudocolor) and MyHC (red pseudocolor) immunofluorescence in 
control (left) and shKv7.4-transfected cells (right); nuclei stained with 
Hoechst are shown in blue pseudocolor. Scale bar, 100 μm. (B) Fusion 
index calculated in both control-transfected (solid column) and 
shKv7.4-transfected (open column) C2C12 cells exposed to DM for 4 d. 
*p ≤ 0.05 vs. control-transfected cells. Values are from independent 
fusion index measurements performed in 15 microscopic fields 
randomly selected from four coverslips for each experimental 
condition (scramble or shKv7.4 transfection).
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left-shifted the midpoint potential of current activation by ∼25 mV 
(V1/2 was –24.5 ± 1.6 and −49.5 ± 5.2 mV in control and retigabine-
exposed currents, respectively; p < 0.05; n = 3–5). No significant 
drug-induced changes were observed in the slope of the normal-
ized current–voltage relationship (the k values were 16.3 ± 2.1 and 
15.8 ± 0.7 in control and retigabine-exposed currents, respectively; 
p > 0.05; n = 3–5; Figure 5B, bottom right).
Changes in REST during skeletal myogenesis 
and effect of manipulating REST on myotube formation 
and Kv7.4 expression in C2C12 cells
In both C2C12 and hSkM-S cells, REST is expressed in immature 
myoblasts, and its transcript (Figure 6A) and protein (Figure 6B) 
levels decline during myotube formation, showing an expression 
pattern opposite to that of Kv7.4. To evaluate whether changes in 
REST expression affect myogenesis and Kv7.4 expression levels, 
with retigabine (10 μM) enhanced the maximal current at depolar-
ized potentials (≥0 mV), with a marked shift in the current activation 
threshold. As a result, during retigabine exposure, Kv7.4 currents 
were already significantly activated at the holding potential of 
−70 mV. In fact, hyperpolarizing pulses from −70 to −100 mV caused 
the channels to deactivate, generating inwardly-directed currents 
that relaxed toward zero (Figure 5B, top right). After washout of 
retigabine, exposure to the Kv7 blocker XE-991 (10 μM) largely 
suppressed the expressed Kv7.4 currents (Figure 5B, bottom left). 
Normalized current–voltage relationships revealed that retigabine 
FIGURE 3: Effect of retigabine on skeletal muscle differentiation in 
shKv7.4-transfected C2C12 cells. mRNA expression analysis by qPCR 
for TnT-1 (A) and Pax3 (B) in control-transfected (open columns) or 
shKv7.4-transfected (solid columns) C2C12 cells exposed to DM for 
48 h in the presence of vehicle (0.1% dimethyl sulfoxide) or retigabine 
(10 μM) as indicated. *p ≤ 0.05 vs. control-transfected C2C12 cells 
exposed to vehicle but not against each other; **p ≤ 0.05 vs. both 
control-transfected C2C12 cells exposed to vehicle and shKv7.4-
transfected C2C12 cells exposed to retigabine; data from three 
separate transfections for each experimental condition (scramble or 
shKv7.4 plasmid).
FIGURE 4: Effect of Kv7.4 overexpression on C2C12 cell 
differentiation. C2C12 myoblasts transfected with pcDNA3.1 (control) 
or pcDNA3.1- Kv7.4 (Kv7.4) were exposed to DM for 48 h. 
(A) Kv7.4, Myog, Pax3, and TnT-1 mRNA expression by qPCR. n = 3–6. 
(B) Western blot analysis for Kv7.4 and MyHC protein expression on 
total lysates from control- or Kv7.4-transfected cells. Top, a 
representative blot for Kv7.4, MyHC, and α-tubulin. The approximate 
molecular mass for each of these proteins (expressed in kDa) is shown 
on the right. Bottom, bar graph showing the quantification of the 
averaged OD values for the Kv7.4 and MyHC bands, normalized to 
the OD value for α-tubulin, in both control-transfected (open columns) 
and Kv7.4-transfected (solid columns) C2C12 cells. *p ≤ 0.05 vs. 
respective controls; data are from three separate transfections for 
each experimental condition (scramble or Kv7.4 plasmid).
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and TnT-1 also in C2C12 cells not exposed to 
DM. The results showed that REST silencing 
did not enhance skeletal muscle differentia-
tion; moreover, in REST-silenced C2C12 myo-
blasts, Kv7.4 levels were also unaffected 
(Supplemental Figure 5).
On the other hand, REST overexpres-
sion largely prevented skeletal muscle 
differentiation in C2C12 cells, as revealed 
by the reduced mRNA levels for Myog, 
TnT-1, and Pax3 upon REST transfection 
(Figure 7A). A significant decrease of 
Kv7.4 mRNA levels was found in REST-
overexpressing cells, whereas no changes 
were observed for Kv7.2. Western blot 
experiments also showed that REST-
transfected cells displayed a marked de-
crease of MyHC and Kv7.4 protein levels 
(Figure 7B).
Differential binding of REST to 
RE1-rich regions in the Kv7.4 gene 
during C2C12 cell differentiation
Members of the Kv7 gene family are under 
direct transcriptional regulation by REST 
(Mucha et al., 2010). Therefore we next in-
vestigated whether a similar mechanism 
might be responsible for the reciprocal 
changes in the expression levels of REST 
and Kv7.4 observed during skeletal myo-
genesis. To this aim, we performed a bioin-
formatic analysis of putative RE1 consensus 
sites for REST binding in the area surround-
ing the transcription start site (TSS) of the 
Kv7.4 genes from various mammalian spe-
cies, including the beginning of the first 
intron. Given the well-known sequence 
variability in the RE1 consensus (Bruce 
et al., 2004), and particularly the presence 
of a 0- to 11-nucleotide (nt) spacer be-
tween the two more-conserved half-site 
regions (Johnson et al., 2008), the input se-
quence for this bioinformatic screening 
was rather degenerated, to gain informa-
tion about most, if not all, potential REST-
binding sites in the Kv7.4 gene region in-
vestigated (see Materials and Methods for 
further details). The results revealed a large 
number of potential RE1 sites, some of 
which clustered within four regions of high 
sequence similarity among Kv7.4 genes from human, rat, and 
mouse (Figure 8A). To test whether REST effectively bound to 
these regions and whether such binding was modified during in 
vitro myogenesis, we performed ChIP experiments in proliferating 
or differentiated C2C12 cells. REST-immunoprecipitated DNA was 
then used in qPCR experiments using primers specifically able to 
amplify each of these four regions. The results revealed that REST 
effectively bound to all four regions in myoblasts and that the oc-
cupancy of sites 1, 3, and 4 was greatly reduced during C2C12 cell 
differentiation into myotubes; no significant difference in REST 
binding between myoblasts and myotubes was found in region 2 
(Figure 8B).
we transiently transfected C2C12 cells with a plasmid coding for a 
short hairpin RNA directed against REST transcripts (shREST) and 
then exposed them to DM. As shown in Figure 6C, in shREST-trans-
fected C2C12 cells, REST mRNA levels were almost completely sup-
pressed; in the same cells, qPCR analysis revealed that Myog, Pax3, 
and TnT-1 levels were markedly increased when compared with 
C2C12 cells differentiated after transfection with a control plasmid. 
In shREST-transfected C2C12 cells, also Kv7.4 mRNA levels were 
increased by ∼10-fold.
To investigate whether the suppression of REST was sufficient to 
trigger the differentiation program in proliferating C2C12 myoblasts, 
we evaluated the effect of REST silencing on the expression of Myog 
FIGURE 5: Effect of retigabine on skeletal muscle differentiation in Kv7.4-transfected C2C12 
cells. (A) mRNA expression analysis by qPCR for TnT-1 (left) and Myog (right) in control-
transfected (open columns) or Kv7.4 (solid columns) transfected C2C12 cells exposed to DM for 
48 h in the presence of vehicle (0.1% dimethyl sulfoxide) or retigabine (10 μM), as indicated. 
*p ≤ 0.05 vs. control-transfected C2C12 cells exposed to vehicle but not against each other; 
**p ≤ 0.05 vs. both control-transfected C2C12 cells exposed to vehicle and Kv7.4-transfected 
C2C12 cells exposed to retigabine; data are from three separate transfections for each 
experimental condition (scramble or Kv7.4 plasmid). (B) Representative macroscopic current 
traces recorded from undifferentiated C2C12 transfected with Kv7.4 before and after application 
of 10 μM retigabine or 10 μM XE-991, as indicated. The voltage protocol is shown below each 
set of traces. The inset shows traces recorded from nontransfected control undifferentiated 
C2C12 cells. Current scale, 200 pA; time scale, 200 ms. Bottom right, steady-state activation 
curves for Kv7.4 channels before and after application of 10 μM retigabine. Continuous lines 
represent Boltzmann fits of the experimental data (data are from three to five cells for each 
experimental condition).
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channels, most notably Kv7.4, accompany 
the myoblast-to-myotube transition in mu-
rine C2C12 cells (Iannotti et al., 2010), with 
similar changes also occurring in human pri-
mary myoblasts. To investigate the role of 
Kv7.4 in skeletal myogenesis, expression 
levels of this gene were down-regulated or 
up-regulated by transfection techniques. 
Transfection with the shKv7.4 plasmid spe-
cifically suppressed Kv7.4 mRNA expression 
in proliferating C2C12 myoblasts, with no ef-
fect on other Kv7 members; this result ar-
gues in favor of the specificity of the silenc-
ing plasmid for its target sequence and 
shows that compensatory mechanisms 
among members of the Kv7 subfamily are 
not taking place. Silencing of Kv7.4 in prolif-
erating C2C12 myoblasts prevents their abil-
ity to initiate the differentiation program, 
suggesting a permissive role for this K+ 
channel subunit in skeletal myogenesis. 
Kv7.4-silenced cells exposed to differentiat-
ing conditions for up to 7 d did not increase 
their cell size and displayed an impaired 
multinucleation, resulting in a marked de-
crease in cell fusion index.
Pharmacological results corroborate the 
hypothesis that Kv7.4 subunits play a cru-
cial role in skeletal myogenesis. In fact, in 
Kv7.4-silenced cells, the effects of the Kv7 
activator retigabine on C2C12 myogenesis 
were abolished, arguing in favor of Kv7.4 
subunits being a major target for the drug-
induced differentiation-promoting effects. 
On the other hand, channels formed by dif-
ferent Kv7 subunits display a differential 
sensitivity to the M-type current inhibitor 
XE-991; in fact, whereas homomeric or het-
eromeric Kv7.2 or Kv7.3 channels display an 
IC50 of ∼1 μM (Wang et al., 1998), currents 
carried by Kv7.4 and Kv7.5 channels display 
IC50s of 5.5 μM (Søgaard et al., 2001) and 
65–75 μM (Schroeder et al., 2000; Yeung et al., 2008), respectively. 
Therefore the observation that XE-991 reduced C2C12 cells differ-
entiation only when used at relatively high concentrations (30 μM) 
suggests a major role for Kv7.4 subunits, possibly in heteromeric 
configuration with Kv7.5 subunits (Schroeder et al., 2000; Bal et al., 
2008; Roura-Ferrer et al., 2008), in skeletal muscle differentiation 
in vitro.
Kv7.4 overexpression in differentiating C2C12 cells failed to ac-
celerate myotube formation, possibly suggesting that the levels of 
Kv7.4 attained during myogenesis were sufficient to allow the 
achievement of the differentiated state. On the other hand, Kv7.4-
overexpressing cells showed an enhanced sensitivity to the differen-
tiation-promoting effects of retigabine when compared with control 
cells. Unfortunately, we failed to record native Kv7 currents in C2C12 
cells, possibly because of their small single-channel conductance 
and opening probabilities (Li et al., 2004; Miceli et al., 2009) or of 
their location in membrane microdomains, which might escape 
electrophysiological detection (Roura-Ferrer et al., 2012). Neverthe-
less, the present electrophysiological results in C2C12 cells overex-
pressing Kv7.4 channels showed that retigabine exposure caused 
DISCUSSION
Kv7.4 as a crucial regulator of skeletal muscle differentiation
Skeletal muscle development is a multifactorial, highly controlled 
process involving the coordinated regulation of a large number of 
genes that allow proliferating myoblasts to withdraw from the cell 
cycle and fuse in ordered arrays of large, multinucleated myotubes, 
which further differentiate into mature muscle fibers (Walsh and 
Perlman, 1997).
An intricate network of reciprocal regulation among myogenic 
regulatory factors controls the early phases of myogenesis (Martin, 
2003). This highly coordinated expression of myogenic factors at 
various stages of skeletal muscle development is strictly dependent 
on changes in membrane potential; in particular, membrane hyper-
polarization underlain by several classes of K+ channels (Wieland 
and Gong, 1995; Fischer-Lougheed et al., 2001) is known to trigger 
the expression of myogenin and myocyte-enhancer factor-2, thus 
exerting a permissive role on the Ca2+-dependent initiation of the 
skeletal muscle differentiation program (Konig et al., 2004).
We previously showed that significant changes in the expression 
levels of some members of the Kv7 subclass of voltage-gated K+ 
FIGURE 6: Changes in REST levels during myotube formation and effect of REST gene silencing 
on C2C12 cell differentiation. (A) REST transcript levels in murine C2C12 and hSkM-S cells 
exposed to GM or to DM, as indicated. n = 3–6 plates of GM- or DM-exposed cells. (B) REST 
expression levels evaluated by Western blot analysis in proliferating myoblasts (GM) and in 
myotubes (DM). Top, a representative blot; the approximate molecular mass for REST and 
α-tubulin (expressed in kDa) is shown on the right. Bottom, quantification of the averaged OD 
values for the REST band, normalized to α-tubulin, in myoblasts (GM) and myotubes (DM). n = 3 
plates of GM- or DM-exposed cells. *p ≤ 0.05 vs. respective control. (C) C2C12 myoblasts 
transfected with control or shREST plasmids were exposed to DM for 48 h. REST, Myog, Pax3, 
TnT-1, and Kv7.4 mRNAs expression levels were evaluated by qPCR. Data are from three to six 
separate transfections for both scramble and shREST plasmid. *p ≤ 0.05 vs. respective control. 
Top, a representative agarose gel electrophoresis of the qPCR products; the size of each band 
corresponds to the predicted amplicon size (Supplemental Table S1).
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and showing abnormal mechanosensitivity (Heidenreich et al., 
2011), lacked a visible phenotype and displayed normal growth and 
development; however, no specific investigation on skeletal muscle 
structure and function has been carried out in these animals, and the 
possibility exists that other K+ channels might compensate in vivo 
for the loss of the myogenesis-promoting effects of Kv7.4.
REST expression changes during myogenesis
In nerve cells, a decrease in REST levels releases the repression of 
hundreds of specific genes, thus orchestrating the acquisition of the 
functional consequences on channel behavior that could not be 
reproduced by Kv7.4 overexpression. In fact, retigabine, in addition 
to increasing the maximal conductance, also caused a marked left-
ward shift in the current activation threshold. Thus, it seems possible 
to speculate that retigabine exposure would increase Kv7.4 partici-
pation in membrane potential control in C2C12 cells, and the result-
ing hyperpolarization would favor skeletal myogenesis; these effects 
would be amplified in Kv7.4-overexpressing cells, thereby explain-
ing their higher sensitivity to the differentiation-promoting effects 
of retigabine.
It should be noticed that mouse models of Kv7.4 deficiency, 
although reproducing some features of the auditory impairment 
observed in humans affected with DFNA2 (Kharkovets et al., 2006) 
FIGURE 7: Effect of REST overexpression on C2C12 cell 
differentiation. (A) REST, Myog, TnT-1, Pax3, Kv7.2, and Kv7.4 mRNA 
expression levels in C2C12 myoblasts transfected with REST. 
(B) Western blot analysis for REST, MyHC, and Kv7.4 protein 
expression in total lysates from control- or REST-transfected cells. The 
inset shows a representative blot for REST, MyHC, Kv7.4, and 
α-tubulin. The approximate molecular mass for each of these proteins 
(expressed in kDa) is shown on the right. The bar graph reports the 
quantification of the averaged OD values for each band, normalized 
to α-tubulin, in both control-transfected (open columns) and REST-
transfected (solid columns) C2C12 cells. *p ≤ 0.05 vs. respective 
control. Data are from three to six separated transfections for each 
experimental condition (scramble or REST plasmid).
FIGURE 8: Bioinformatic and ChIP analysis of putative RE1 sites in 
the Kv7.4 gene. (A) A schematic representation of ∼2500 nt upstream 
and of ∼ 500 nt downstream from the TSS in the human Kv7.4 gene. 
The black and light gray boxes correspond to regions of high 
sequence homology between the mouse and the human genes, and 
the rat and the human genes, respectively. RE-1 sites identified are 
shown as small squares in the lower part. RE1 sites are indicated 
relative to the number of nucleotides in the spacer region separating 
the hemihalves of the RE1 canonical sequence, as indicated on the 
left. Regions identified as 1–4, indicated by the broken boxes, 
correspond to RE1-containing gene regions of high sequence 
homology among species. (B) REST occupancy of Kv7.4 RE1 sites 
evaluated by ChIP. Average data of the relative amount of the 
REST-immunoprecipitated DNA in both myoblasts and myotubes are 
shown in the bar graph; data are normalized relative to the input 
DNA, using the 2−ΔCt formula. Data are from three to six separate 
experiments in GM- or DM-exposed C2C12 cells. *p ≤ 0.05 vs. 
respective control. The inset shows a representative agarose gel 
electrophoresis of the qPCR products obtained from REST-
immunoprecipitated DNA from both C2C12 myoblasts (open columns; 
GM) and myotubes (solid columns; DM). Control lanes corresponding 
to amplification products obtained using DNA inputs or 
immunoglobulin G–immunoprecipitated DNA as a template for each 
primer pairs are also shown.
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enhanced expression of Kv7.4 in C2C12 cells, whereas, despite the 
low levels of REST, mature DRG neurons express low (Heidenreich 
et al., 2011) or undetectable (Passmore et al., 2003) Kv7.4 levels. A 
complex cross-talk among families of factors acting as activators, in-
cluding Sp1 (Mucha et al., 2010), thyroid hormone receptors (Winter 
et al., 2006), and Pit1 (Mustapha et al., 2009), or repressors, such as 
REST (Mucha et al., 2010), of Kv7 gene transcription is likely respon-
sible for such phenomenon. Indeed, several Sp1 sites are also pres-
ent in the REST-binding regions identified here in the Kv7.4 gene.
Conclusion
The present results suggest that REST-regulated Kv7.4 channels play 
a crucial role in the induction and/or maintenance of the differenti-
ated state in skeletal myotubes and highlight REST as a crucial regu-
lator of skeletal muscle differentiation fate. In view of the described 
dysregulation of REST-target genes in myofibrillar myopathies 
(Barrachina et al., 2007), the novel mechanism described here may 
be a relevant target for intervention against skeletal muscle diseases 
characterized by abnormal repair and differentiation.
MATERIALS AND METHODS
Cell culture
C2C12 myoblasts were cultured and differentiated as previously 
described (Iannotti et al., 2010). Briefly, proliferating C2C12 cells 
were propagated in a growth medium (GM) composed of DMEM 
(Life Technologies Italia, Milan, Italy) supplemented with 10% fetal 
bovine serum (FBS), 50 U/ml penicillin plus 50 μg/ml streptomycin, 
and 1% l-glutamine (Invitrogen, Milan, Italy) in a humidified atmo-
sphere of 95% air/5% CO2 at 37°C. Myotube differentiation was 
achieved upon exposure of proliferating C2C12 cells to a lower 
(0.1%) FBS concentration, plus 5 μg/ml insulin and 5 μg/ml apo-
transferrin (differentiation medium) for 2–7 d, according to the ex-
perimental protocol. Human primary myoblasts (hSKM-S; A12555, 
Invitrogen) were cultured in GM and differentiated upon exposure 
to DMEM plus 2% horse serum, according to the manufacturer’s 
instructions.
Cell transfection, RNA extraction, and quantitative 
real-time PCR
C2C12 cells were plated in 60-mm culture dishes; the day after 
plating, cells were transfected with the plasmids of interest using 
Lipofectamine 2000 (Invitrogen), according to the manufacturer’s 
instructions, together with a plasmid encoding for the enhanced 
green fluorescent protein (Clontech, Mountain View, CA) to assess 
transfection efficiency. Total cDNA in the transfection mixture was 
kept constant at 8 μg. For qPCR and Western blot experiments, 24 
h after transfection C2C12 cells were exposed to DM for 2 d. In time-
course immunofluorescence assays, in order to prolong transcript 
suppression of the Kv7.4 by the silencing strategy, we exposed 
shKv7.4 or scramble-transfected C2C12 cells to selection media con-
taining 1.5 μg/ml puromycin for 2 d; after this period, cells were 
plated on poly-l-lysine–coated coverslip, allowed to adhere for fur-
ther 24 h, and then exposed to DM (puromycin supplemented) for 
different times (Mancini et al., 2011). Total RNA isolation, purifica-
tion, and cDNA synthesis were performed as described (Iannotti 
et al., 2010). qPCR was carried out in a real-time PCR system (7500 
fast; Applied Biosystems, Monza, Italy) using the SYBR Green de-
tection technique and specific primers (Supplemental Table S1). 
Samples were amplified simultaneously in triplicate in a one-assay 
run with a nontemplate control blank for each primer pair to control 
for contamination or primer-dimer formation, and the cycle thresh-
old (Ct) value for each experimental group was determined. 
differentiated phenotype (D’Alessandro and Meldolesi, 2010). Rat 
L6 myoblasts express high levels of REST activity (Chong et al., 
1995; Seth and Majzoub, 2001); in these cells, the inhibition of REST 
derepresses non-muscle–specific proteins, such as the brain type II 
voltage-gated sodium channel (Chong et al., 1995).
Our results show that the expression levels of REST inversely cor-
related with the differentiation stage in both C2C12 cells and human 
primary myoblasts, being lower at later developmental stages. 
Moreover, REST level modulation strongly regulates skeletal muscle 
differentiation, and high levels of REST contribute to the suppres-
sion of the differentiation program in proliferating skeletal muscle 
cells. However, the observation that REST suppression in C2C12 
myoblasts grown under proliferating conditions did not enhance the 
expression of skeletal muscle–specific genes suggests that, in the 
absence of other molecular triggers, REST suppression alone is not 
sufficient to sustain the acquisition of the myogenic program. Simi-
lar hypotheses have been also put forward to explain REST-induced 
regulation of genes involved in neuronal differentiation (Majumder, 
2006).
REST-induced regulation of Kv7.4 expression 
during myogenesis
Kv7.2 and Kv7.3 genes are direct targets for regulation by REST in 
sensory cells of the dorsal root ganglia (DRG; Mucha et al., 2010), 
and REST-induced down-regulation of Kv7.2 contributes to DRG 
overexcitability during neuropathic pain states (Rose et al., 2011). 
Our results show that REST levels are inversely related also to those 
for Kv7.4. In fact, Kv7.4 transcript levels were significantly reduced in 
REST-transfected C2C12 cells, whereas they were markedly enhanced 
upon REST silencing. Potential REST-binding RE1 sites in the Kv7.4 
gene were identified by bioinformatics analysis; these clustered 
within four regions of high sequence homology among human, 
rat, and mouse species located between ∼2500 nt upstream and 
∼500 nt downstream from the TSS of the Kv7.4 gene. ChIP experi-
ments revealed that REST effectively bound to these four regions, 
and, more important, that REST-binding efficiency was decreased in 
myotubes when compared with myoblasts at three of them. These 
results suggest that a reduction in REST binding to RE1 sites in the 
Kv7.4 gene during skeletal muscle differentiation might enhance 
Kv7.4 transcription, allowing this K+-channel gene to exert its per-
missive role on myogenesis
Tissue-specific regulation of Kv7 genes by REST
As already introduced, Mucha et al. (2010) identified an RE1 site, 
conserved among various species, located in the first intron of the 
Kv7.2 gene, ∼10 kb downstream of the first exon. Bioinformatic anal-
ysis of the corresponding position of all Kv7 gene members revealed 
that the RE-1 sequence identified in Kv7.2 also had high matching 
scores in Kv7.3 and Kv7.5 genes but low scores in Kv7.1 and Kv7.4; 
electromobility shift assays confirmed the ability of REST to bind to 
this RE1 site in Kv7.2, Kv7.3, and Kv7.5 but not in Kv7.1 or Kv7.4 
genes. In the present experiments, given the strong sequence vari-
ability in the potential RE1 sites (Johnson et al., 2008), we used a 
consensus sequence more degenerated than that used in Mucha 
et al. (2010). This strategy allowed the identification of regulatory 
regions distinct from those of Mucha et al. (2010). Taken together, 
these data are strongly suggestive of a marked tissue-specific tran-
scriptional regulation of the different Kv7 gene family members. In 
fact, Kv7.2 transcript levels in DRGs seem to be highly regulated by 
REST (Mucha et al., 2010); by contrast, in C2C12 cells, Kv7.2 tran-
script levels appear insensitive to changes in REST levels. Moreover, 
a decrease in REST levels during myogenesis contributes to the 
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+1950 relative to the TSS), where N = A, C, G, or T; B = C, G, or T; Y 
= C or T; M = A or C; R = A or G; and S = C or G. Each putative RE1 
site identified showed a homology score of >85%. ChIP assays were 
performed following published protocols (Formisano et al., 2007), 
with slight modifications. Briefly, C2C12 cells were cross-linked in 1% 
formaldehyde for 20 min at room temperature. The cross-linking 
reaction was stopped by adding glycine to a final concentration of 
0.125 M. The cells were washed two times in cold PBS containing 
protease inhibitors (Sigma-Aldrich), and cell lysates were prepared 
and sonicated to generate chromosomal DNA in the range of 400–
600 base pairs. Sonicated DNA was precleared with salmon sperm 
DNA/protein G-agarose 50% gel slurry for 1 h at 4°C and immuno-
precipitated overnight at 4°C with rabbit polyclonal antibodies di-
rected against the N-terminus of REST (REST-N; 1:300; Santa Cruz 
Biotechnology, Santa Cruz, CA). After washes and elution, immuno-
precipitated DNA was released from histones (65°C for 4 h in 5 M 
NaCl), treated with proteinase K (1 h at 45°C), purified by phenol-
chloroform extraction and ethanol precipitation, and finally resus-
pended in PCR-grade water. Immunoprecipitated DNA was ana-
lyzed by qPCR (40–45 cycles) using primers amplifying each of the 
four RE1-rich regions identified (Supplemental Table S1). DNA 
immunoprecipitated by anti–rabbit immunoglobulin G antibodies 
(GE Healthcare Europe, Milan, Italy) was used as a negative control. 
In addition, for each primer pair, nonimmunoprecipitated DNA was 
used as input for normalization. All ChIP assays were performed in 
triplicate for at least three different biological preparations.
Western blots
C2C12 cells were washed twice in cold PBS and lysed with lysis solu-
tion (150 mM NaCl, 1 mM EDTA, pH 7.4, 10 mM Tris-HCl, pH 8, 1% 
SDS, and protease inhibitors). Lysates were sonicated for 40–60 s 
and then boiled for 5 min in Laemmli SDS loading buffer, loaded 
(100–150 μg) on 8% SDS–PAGE, and then transferred to a polyvi-
nylidene fluoride membrane. Filters were incubated overnight at 
4°C with the following antibodies: rabbit anti-REST (1:400; Millipore, 
Temecula, CA); mouse anti-Kv7.4 (1:500; Neuromab, Davis, CA); 
and mouse anti-MyHC (1:1000; Millipore). An anti α-tubulin anti-
body (1:5000; Sigma-Aldrich) was used to check for equal protein 
loading. Reactive bands were detected by chemiluminescence (ECL 
or ECL-plus; Amersham Bioscience, Piscataway, NJ). Images were 
analyzed on a ChemiDoc station with Quantityone software (Bio-
Rad, Segrate, Italy).
Drugs and other reagents
Retigabine was from ASTA Medica (Radebeul, Germany) or Valeant 
Pharmaceuticals (Aliso Viejo, CA); XE-991 was from Tocris Bio science 
(Bristol, United Kingdom). The expression plasmid pcDNA3.1-REST 
was kindly provided by R. Suzanne Zukin (Department of Neuro-
science, Albert Einstein College of Medicine, New York, NY). The 
shRNA lentiviral plasmid designed to silence Kv7.4 gene expression 
(pKLO.1-shKv7.4; 5′-CCGGCCGTTCTGTCAGGATTCTGAACTC-
GAGTTCAGAATCCTGACAGAACGGTTTT-3′) was from Sigma-
Aldrich (Ref. Seq. XM_143960). The nonsense pLKO.1-puro plasmid 
containing a scrambled sequence was obtained from Addgene 
(Cambridge, MA). The shRNA lentiviral plasmid (psMagic2-amp) en-
coding a short sequence 5′-GCGCCCAGATATTTACAGTTCAAATT-
AGTGAAGCCACAGATGTAATTTGAACTGTAAATATCTGGA TGT-
3′) directed against REST mRNA (shREST), as well as the scrambled 
plasmid used as control, were from Open Biosystems (Huntsville, 
AL) and were kindly provided by Lucio Pastore (Department of 
Medical Biotechnology, University of Naples Federico II, Naples, 
Italy).
A housekeeping gene (the ribosomal protein S16) was used as an 
internal control to normalize the Ct values, using the 2−ΔCt formula; 
differences in mRNA content between groups were as expressed 
as 2−ΔΔCt, as previously described (Winer et al., 1999).
Immunofluorescence
C2C12 cells were washed twice in ice-cold phosphate-buffered sa-
line (PBS) and fixed with 2% paraformaldehyde for 15 min at room 
temperature (RT; 20–22°C). Cells were treated with 0.1 M glycine for 
5 min and incubated overnight at 4°C with the following primary 
antibodies: mouse anti-MyHC (1:100; Sigma-Aldrich, Milan, Italy) 
and rabbit anti-Kv7.4 (1:100; Abcam, Cambridge, United Kingdom). 
Cells were then washed for 30 min with PBS, incubated for 1 h at RT 
with anti-mouse conjugated to Cy3 or anti-rabbit conjugated to Al-
exa Fluor 488 (1:100; Jackson ImmunoResearch, Newmarket, United 
Kingdom), and counterstained with Hoechst 33258 (0.2 μg/ml, 
10 min at RT; Sigma-Aldrich) to visualize cells nuclei. All antibodies 
and Hoechst 33258 were diluted in PBS containing 0.1% Triton 
X-100 and 1% bovine serum albumin. Coverslips were mounted in 
Fluoromount (Sigma-Aldrich) and analyzed using a Zeiss LSM 
510 Meta argon/krypton laser scanning confocal microscope (Carl 
Zeiss, Jena, Germany). Images were acquired using the multitrack 
system to avoid cross-talk among channels. The excitation/emission 
settings were as follows: 430/505–550 nm for Alexa Fluor 488 and 
543/560–615 nm for CY3. Images were confocally captured using a 
20× objective (PlanApochromat, numerical aperture, 1.4) pinhole, 
<1 Airy unit. Each image was acquired eight times, and the signal 
averaged to improve the signal-to-noise ratio. The fusion index was 
defined as the percentage of nuclei inside the myotubes; myotubes 
were identified as MyHC-positive cells containing three or more nu-
clei, as previously described (Mancini et al., 2011).
Whole-cell electrophysiology
Currents from C2C12 cells were recorded at room temperature 
(20–22°C) 1 d after transfection with an Axopatch 200A (Molecular 
Devices, Union City, CA) using the perforated whole-cell configu-
ration of the patch-clamp technique, with glass micropipettes 
of 3–5 MΩ resistance. The extracellular solution contained 
(mM): 138 NaCl, 2 CaCl2, 5.4 KCl, 1 MgCl2, 10 glucose, and 10 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 
pH 7.4, with NaOH. The pipette (intracellular) solution contained 
(mM): 140 KCl, 2 MgCl2, 10 ethylene glycol tetraacetic acid, 
10 HEPES, 5 Mg-ATP, pH 7.3–7.4, with KOH. Nystatin (120–
240 μg/ml) was added to this solution immediately before each 
recording session. The pCLAMP software (version 10.0.2; Mole-
cular Devices) was used for data acquisition and analysis. To gener-
ate conductance–voltage curves, the cells were held at −70 mV 
and then depolarized for 1.5 s from −100/−80 to 0/+20 mV in 
10-mV increments, followed by an isopotential pulse at 0 mV of 
350-ms duration. The current values recorded at the beginning 
of the 0-mV pulse were normalized and expressed as a function of 
the preceding voltages. The data were fitted to a Boltzmann equa-
tion of the following form: y = max/[1 + exp(V1/2 − V)/k], where V is 
the test potential, V1/2 is the half-activation potential, and k is the 
slope factor.
Bioinformatic analysis and chromatin 
immunoprecipitation assays
Kv7.4 sequence alignments and potential RE1 consensus sites iden-
tification were performed using Lasergene software (DNASTAR, 
Madison, WI). The sequence NBYAGMRCC(2-10N)RGMSAGNNNC 
was used to identify RE1 sites in the Kv7.4 gene (from−3360 to 
Volume 24 February 1, 2013 Kv7.4 in skeletal muscle differentiation | 283 
Statistics
Data are expressed as mean ± SEM of the given number of experi-
ments (n); for qPCR experiments, each data point was performed in 
triplicate. Data sets were compared by use of matched Student’s t 
tests or, if necessary, with one-way analysis of variance, followed by 
the Newman-Keuls test. Statistically significant differences were ac-
cepted when p was ≤0.05.
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